UBS Group »

Kyverna Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Kyverna Therapeutics

May 2024Jul 2024Sep 2024Nov 2024Jan 20250200k400k600k800k050k100k150k200k
Value ($)Share countHistorical KYTX position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $761k 203k 3.74
2024-09-30 $40k 8.2k 4.89
2024-06-30 $72k 9.6k 7.50
2024-03-31 $619k 25k 24.84

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Novo A/S
BlackRock
Vanguard Group
Insight Holdings
Millennium Management
Franklin Resources
Mbb Public Markets I
T. Rowe Price Associates
Geode Capital Management
Jacobs Levy Equity Management
State Street Corporation

View all funds holding Kyverna Therapeutics